Br Biochem Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-07-2024
- Paid Up Capital ₹ 0.75 M
as on 25-07-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 25-07-2024
- Satisfied Charges ₹ 1.50 Cr
as on 25-07-2024
- Revenue -14.75%
(FY 2023)
- Profit -8.93%
(FY 2023)
- Ebitda 65.61%
(FY 2023)
- Net Worth 15.07%
(FY 2023)
- Total Assets -3.07%
(FY 2023)
About Br Biochem Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Babita Negi and Rakesh Singh serve as directors at the Company.
- CIN/LLPIN
U51900DL2012PTC237423
- Company No.
237423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Br Biochem Life Sciences Private Limited offer?
Br Biochem Life Sciences Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Consumables, Bulk Bags & Sacks, Garbage and Waste Bags, Medical Refrigerator Systems, Freeze Dryers, Ultrasonic Cleaner, Pathology Lab Equipments, DNA Ladder, Spectrophotometer.
Who are the key members and board of directors at Br Biochem Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babita Negi  | Director | 13-Jun-2012 | Current |
| Rakesh Singh | Director | 13-Jun-2012 | Current |
Financial Performance of Br Biochem Life Sciences.
Br Biochem Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.75% decrease. The company also saw a slight decrease in profitability, with a 8.93% decrease in profit. The company's net worth Soared by an impressive increase of 15.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Br Biochem Life Sciences?
In 2023, Br Biochem Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Jul 2022 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Sep 2016 | ₹1.00 Cr | Satisfied |
Deutsche Bank Ag Creation Date: 15 Jan 2015 | ₹5.00 M | Satisfied |
How Many Employees Work at Br Biochem Life Sciences?
Br Biochem Life Sciences has a workforce of 8 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Br Biochem Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Br Biochem Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
